SYNBIOTICS CORP

SYNBIOTICS CORP

Synbiotics Corporation develops, manufactures, and markets rapid immunodiagnostic and laboratory diagnostic products for the veterinary and animal health care industry. The company's portfolio serves veterinary practices, livestock and poultry producers, reference laboratories, and animal breeders globally across the United States, Canada, Europe, Africa, Asia, Oceania, and Latin America. Synbiotics specializes in diagnostic tests for both companion animals and food production animals, competing in the specialized animal diagnostics sector. Key risks include market competition from larger diagnostics companies, regulatory approval requirements for new products, and dependence on veterinary and agricultural markets. The company was ultimately acquired by Pfizer Animal Health in December 2010. Investors can review detailed financial information and SEC filings for Synbiotics Corporation (CIK 719483) on Earnings Feed.